Rutgers center sparks 'liquid bandage,' a new frontline wound treatment

The Center for Military Biomaterials Research (CeMBR), part of the New Jersey Center for Biomaterials at Rutgers University, has enabled the development of a breakthrough spray-on dressing for injuries. The trademarked GelSpray Liquid Bandage by BioCure Inc., a medical device company in Norcross, Ga., received clearance for marketing from the U.S. Food and Drug Administration (FDA) Feb. 1.

The GelSpray Liquid Bandage is a major advance in the management and care of combat casualty and civilian wounds. Much like epoxy is dispensed in household kits, the dressing is applied with a dual syringe that releases two polymer ingredients. These polymers react rapidly upon mixing to form a gel-based dressing that frontline combat soldiers can apply to their own wounds. The dressing conforms to the wound geometry, adheres to intact skin but not directly to the injured tissue, and resists abrasion.

While created for the military, the GelSpray technology has potential uses in civilian health care. Future versions of the liquid bandage may be suitable for use by civilian rescue teams to treat traumatic wounds and burns, as well as in the treatment of diabetic ulcers, ostomies and post-op wounds. Future products based on the GelSpray technology platform will include active ingredients to treat infection and pain, and control severe bleeding.

Rutgers’ Center for Military Biomaterials Research was created to link academia, industry and the military to fulfill urgent military medical care needs. Its mission is to familiarize the biomedical research community with the unique needs of combat casualty care and to foster the development of innovative medical technologies to treat injured soldiers. The center is supported with funding from the U.S. Army Medical Research and Materiel Command (USAMRMC) and its Telemedicine and Advanced Technologies Research Center at Fort Detrick, Md.

“In this case, it was the mission of our center to collaborate with industry to conduct research that resulted in a new product,” said Joachim Kohn, the principal investigator at CeMBR and Board of Governors Professor of Chemistry at Rutgers.

In the collaboration with BioCure, the Rutgers center supported the research part of the product development effort with funding from the USAMRMC. Kohn explained that the close collaboration among BioCure, the U.S. Army and Rutgers moved the project rapidly from concept to FDA market clearance. “The process took about three and a half years – a truly remarkable achievement,” Kohn added.

Source: Rutgers University

Related stories:

Researchers probe geographical ties to ALS cases among 1991 Gulf War veterans
Researchers from Duke University, the University of Cincinnati and the Durham Veterans Administration Medical Center are hoping to find a geographical pattern to help explain why 1991 Gulf War veterans contracted the fatal neurological disease amyotrophic lateral sclerosis (ALS) at twice the normal rate during the decade after the conflict.
Gene variant found in those with African ancestry increases odds of HIV infection
A variant of a gene found only in people of African ancestry increases the odds of becoming infected with the human immunodeficiency virus (HIV-1) by 40 percent, according to a long-term study of African Americans reported in the [date] issue of the journal Cell Host & Microbe, a publication of Cell Press. However, once people are infected, the same variant seems to protect against progression of the disease, allowing those who carry it to live about two years longer.
Scientists close in on source of X-rays in lightning
University of Florida and Florida Institute of Technology engineering researchers have narrowed the search for the source of X-rays emitted by lightning, a feat that could one day help predict where lightning will strike.
More kidney stone disease projected due to global warming
Global warming is likely to increase the proportion of the population affected by kidney stones by expanding the higher-risk region known as the "kidney-stone belt" into neighboring states, researchers at UT Southwestern Medical Center and UT Dallas have found.
Doctors hopeful easier blood thinners are nearing
(AP) -- A trio of experimental drugs has doctors hopeful that for the first time in decades, millions of people at risk of lethal blood clots may soon get easier treatment.
Remote Alaska volcano erupts, spewing rock and ash
(AP) -- A volcano erupted Saturday with little warning on a remote island in Alaska, sending residents of a nearby ranch fleeing from falling ash and volcanic rock.
Research identifies brain cells related to fear
The National Institute of Mental Health estimates that in any given year, about
40 million adults (18 or older) will suffer from some form of anxiety disorder, including debilitating conditions such as phobias, panic disorders and post-traumatic stress disorder (PTSD). It is estimated that nearly 15 percent of U.S. soldiers returning from Iraq and Afghanistan develop PTSD, underscoring the urgency to develop better treatment strategies for anxiety disorders. These disorders can lead to myriad problems that hinder daily life – or ruin it altogether – such as drug abuse, alcoholism, marital problems, unemployment and suicide.
Nano-sized electronic circuit promises bright view of early universe
A newly developed nano-sized electronic device is an important step toward helping astronomers see invisible light dating from the creation of the universe. This invisible light makes up 98% of the light emitted since the "big bang," and may provide insights into the earliest stages of star and galaxy formation almost 14 billion years ago.

News discussion:

Medicine & Health news